- Home
- EPIX vs INCR Comparison
EPIX vs INCR Comparison
Compare EPIX & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- INCR
- Stock Information
- Founded
- EPIX 2009
- INCR 1994
- Country
- EPIX Canada
- INCR Israel
- Employees
- EPIX N/A
- INCR N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- EPIX Health Care
- INCR Health Care
- Exchange
- EPIX Nasdaq
- INCR Nasdaq
- Market Cap
- EPIX 65.3M
- INCR 76.7M
- IPO Year
- EPIX N/A
- INCR N/A
- Fundamental
- Price
- EPIX $1.72
- INCR $1.59
- Analyst Decision
- EPIX Hold
- INCR
- Analyst Count
- EPIX 3
- INCR 0
- Target Price
- EPIX $2.00
- INCR N/A
- AVG Volume (30 Days)
- EPIX 280.5K
- INCR 14.0K
- Earning Date
- EPIX 05-08-2025
- INCR 05-01-2025
- Dividend Yield
- EPIX N/A
- INCR N/A
- EPS Growth
- EPIX N/A
- INCR N/A
- EPS
- EPIX N/A
- INCR N/A
- Revenue
- EPIX N/A
- INCR $65,575,323.00
- Revenue This Year
- EPIX N/A
- INCR $69.54
- Revenue Next Year
- EPIX N/A
- INCR $41.75
- P/E Ratio
- EPIX N/A
- INCR N/A
- Revenue Growth
- EPIX N/A
- INCR N/A
- 52 Week Low
- EPIX $1.40
- INCR $1.17
- 52 Week High
- EPIX $7.88
- INCR $3.39
- Technical
- Relative Strength Index (RSI)
- EPIX 52.43
- INCR 61.63
- Support Level
- EPIX $1.67
- INCR $1.56
- Resistance Level
- EPIX $1.79
- INCR $1.31
- Average True Range (ATR)
- EPIX 0.08
- INCR 0.08
- MACD
- EPIX -0.01
- INCR 0.02
- Stochastic Oscillator
- EPIX 21.28
- INCR 84.38
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.